Haemolytic uraemic syndrome is a form of thrombotic microangiopathy affecting
predominantly the kidney and characterised by a triad of thrombocytopenia, mechanical …

Although Escherichia coli can be an innocuous resident of the gastrointestinal tract, it also
has the pathogenic capacity to cause significant diarrheal and extraintestinal diseases …

The severity of human infection by one of the many Shiga toxin-producing Escherichia coli
(STEC) is determined by a number of factors: the bacterial genome, the capacity of human …

Importance Identification of the bacterium responsible for an outbreak can aid in disease
management. However, traditional culture-based diagnosis can be difficult, particularly if no …

Background. Antibiotic administration to individuals with Shiga toxin–producing Escherichia
coli (STEC) infection remains controversial. We assessed if antibiotic administration to …

Objective To evaluate the effect of different treatment strategies on enterohaemorrhagic
Escherichia coli O104: H4 induced haemolytic uraemic syndrome. Design Multicentre …

Abstract Background. Escherichia coli O157: H7 is the leading cause of hemolytic uremic
syndrome (HUS). Risk factors for development of this complication warrant identification …

First described by Gasser and colleagues 1 in 1955, hemolytic uremic syndrome (HUS) is
the clinical triad of thrombocytopenia, anemia, and acute kidney injury. It is classically …

Haemolytic uraemic syndrome (HUS) is defined by the simultaneous occurrence of
nonimmune haemolytic anaemia, thrombocytopenia and acute renal failure. This leads to …

Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy defined by
thrombocytopenia, nonimmune microangiopathic hemolytic anemia, and acute renal failure …